(NASDAQ: ALGN) Align Technology's forecast annual revenue growth rate of 6.38% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.02%.
Align Technology's revenue in 2025 is $3,960,519,000.On average, 6 Wall Street analysts forecast ALGN's revenue for 2025 to be $312,973,995,683, with the lowest ALGN revenue forecast at $307,907,292,501, and the highest ALGN revenue forecast at $317,095,591,125. On average, 5 Wall Street analysts forecast ALGN's revenue for 2026 to be $333,307,548,247, with the lowest ALGN revenue forecast at $328,993,795,828, and the highest ALGN revenue forecast at $337,685,651,604.
In 2027, ALGN is forecast to generate $359,969,590,014 in revenue, with the lowest revenue forecast at $359,969,590,014 and the highest revenue forecast at $359,969,590,014.